Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
5 authors.
Sara L N Kilmury *Department of Biochemistry and Biomedical Sciences and the Michael G DGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
Katherine J Graham *Department of Biochemistry and Biomedical Sciences and the Michael G DGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
Ryan P LamersDepartment of Biochemistry and Biomedical Sciences and the Michael G DGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
Lesley T MacNeilDepartment of Biochemistry and Biomedical Sciences and the Michael G DGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
Lori L BurrowsDepartment of Biochemistry and Biomedical Sciences and the Michael G DGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0003-0838-5040
Funding
Canada Research Chairs (Chaires de recherche du Canada) CRC-2021-00103Canadian Government | Canadian Institutes of Health Research (CIHR) CGS-MCanadian Government | Canadian Institutes of Health Research (CIHR) PJT-156080Canadian Government | Canadian Institutes of Health Research (CIHR) Postdoctoral FellowshipCystic Fibrosis Canada (CF) FellowshipGovernment of Ontario (Ontario Government) OGS
6 · The paper itself
Abstract
Type IVa pili (T4aP) are important virulence factors for many bacterial pathogens. Previous studies suggested that the retraction ATPase, PilT, modulates pathogenicity due to its critical role in pilus dynamics and twitching motility. Here we use a
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Hyperpiliation, not loss of pilus retraction, reduces · full record | OpenQuestion